This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reddel, R. R. Articles by Sutherland, R. L. Search for Related Content PubMed PubMed Citation Articles by Reddel, R. R. Articles by Sutherland, R. L.

Effects of Pharmacological Concentrations of Estrogens on Proliferation and Cell Cycle Kinetics of Human Breast Cancer Cell Lines in Vitro¹

Garvan Institute of Medical Research [R. L. S.], St. Vincent's Hospital, Sydney, N.S.W. 2010, and Ludwig Institute for Cancer Research (Sydney Branch) [R. R. R.], University of Sydney, N.S.W. 2006 Australia

High dose estrogen therapy has been used effectively in the treatment of human breast cancer. To understand the mechanisms involved, the effects of high concentrations (5–100 µM) of estrogens were studied in estrogen receptor (ER) positive (T-47D and MCF-7) and ER negative (MDA-MB-330) human breast cancer cell lines in vitro. Inhibition of cellular proliferation was seen with the synthetic estrogen diethylstilbestrol (DES) at concentrations >10 µM in each of the three cell lines. In T-47D cells DES was shown by clonogenic survival assays to be cytotoxic. This effect was evident in both plateau phase and exponentially growing cultures, in contrast to the effects of the antiestrogen tamoxifen, which has minimal effects on plateau phase cells. The effects of DES on the proliferation of exponentially growing cultures were accompanied by changes in cell cycle parameters which included an increase in the percentages of S-phase, G₂ + M, and polyploid cells and a corresponding decrease in the percentage of G₀-G₁ cells. These changes, which contrasted with the known effects of tamoxifen, were not seen in the non- or slowly cycling plateau phase T-47D cells. Such results are consistent with two mechanisms of action of high dose estrogen in vitro: a cell cycle phase-specific effect and cell cycle-independent cytotoxicity.

The stereoisomers 17-estradiol and 17ß-estradiol had similar potency to DES in inhibiting cell proliferation and inducing these changes in cell cycle parameters in both MCF-7 and MDA-MB-330 cells. The high-dose estrogen effect was ligand specific in that estrone and estriol were less potent than DES, 17-estradiol and 17ß-estradiol in inhibiting cell proliferation, and the characteristic cell cycle changes were produced only by concentrations of estriol >75 µM and not at all by estrone at concentrations up to 100 µM. The androgens testosterone and dihydrotestosterone were similar in effect to estrone.

The cell cycle changes associated with estrogen-induced growth inhibition in vitro are identical to those observed during regression of ER positive but not ER negative human tumor xenografts in nude mice. However, the role of ER in mediating estrogen-induced regression of ER positive tumors in vivo remains undefined.

¹ Supported by the National Health and Medical Research Council of Australia.

² Present address: Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, MD 20892.

³ To whom requests for reprints should be addressed, at the Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, N.S.W. 2010 Australia.

Received 6/26/86. Revised 6/19/87. Accepted 7/22/87.

This article has been cited by other articles:

				Z.-Y. Zheng, B.-H. Bay, S.-E. Aw, and V. C-L. Lin A Novel Antiestrogenic Mechanism in Progesterone Receptor-transfected Breast Cancer Cells J. Biol. Chem., April 29, 2005; 280(17): 17480 - 17487. [Abstract] [Full Text] [PDF]

				Q. Xu and C. Lee Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences Nucleic Acids Res., October 1, 2003; 31(19): 5635 - 5643. [Abstract] [Full Text] [PDF]

				D. Lu, Y. Kiriyama, K. Y. Lee, and V. Giguere Transcriptional Regulation of the Estrogen-inducible pS2 Breast Cancer Marker Gene by the ERR Family of Orphan Nuclear Receptors Cancer Res., September 1, 2001; 61(18): 6755 - 6761. [Abstract] [Full Text] [PDF]